about
PIM-1 kinase expression in adipocytic neoplasms: diagnostic and biological implications.Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgeryA comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets.Exome sequencing reveals recurrent REV3L mutations in cisplatin-resistant squamous cell carcinoma of head and neck.TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery.Positive association between nuclear Runx2 and oestrogen-progesterone receptor gene expression characterises a biological subtype of breast cancer.The relevance of molecular diagnostics in the practice of surgical pathology.Molecular cytogenetics: recent developments and applications in cancer.Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.Frequent Coamplification of Receptor Tyrosine Kinase and Downstream Signaling Genes in Japanese Primary Gastric Cancer and Conversion in Matched Lymph Node Metastasis.RNH1 regulation of reactive oxygen species contributes to histone deacetylase inhibitor resistance in gastric cancer cells.Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer.Characterization of Numb expression in astrocytomas.SETD2 histone modifier loss in aggressive GI stromal tumours.Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer.Mutually exclusive FGFR2, HER2, and KRAS gene amplifications in gastric cancer revealed by multicolour FISH.Aurora-A expression, hormone receptor status and clinical outcome in hormone related cancers.Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer.KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status.Genomic predictors of chemotherapy efficacy in advanced or recurrent gastric cancer in the GC0301/TOP002 phase III clinical trial.Acquired Resistance to FGFR Inhibitor in Diffuse-Type Gastric Cancer through an AKT-Independent PKC-Mediated Phosphorylation of GSK3β.Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development.Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancerNew insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expressionDifferential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladderChromosomal changes in prostate cancer: a fluorescence in situ hybridization studyAn LCM-based genomic analysis of SPEM, Gastric Cancer and Pyloric Gland Adenoma in an Asian cohort
P50
Q33273560-F9B518E4-8C7C-4C00-A47B-9BCF6E768ACBQ35112054-A400AB6E-65A1-4AC9-A198-94497181B913Q35878807-205E9DFF-FBC7-4B6E-9F39-4F0BF5E3BC17Q36500914-3C3FD394-EC88-4166-82F7-74651C5FFF4FQ37208515-C25129AF-B099-40CE-8EEA-99002CC8AFF9Q37323255-8DAFF555-C30B-4670-86A6-F536FA330309Q38089953-A46F9622-53E3-4DDF-B9F9-288E490B106FQ38119502-84A9C57A-D0CA-4737-A926-0527973E5C5AQ38490073-4A9F6C74-23F6-4EA2-8379-47A8D2342268Q38806016-594604F0-B1C5-423F-9F3F-625D2ACF5710Q39166818-189FB753-3606-4837-99D5-E5F18E9BD577Q39574504-6AFEF689-4638-47A7-B5C5-964725A19016Q39995761-DDB70E8D-DC4C-4C36-BCE1-FB9EB2EF3C9AQ40575285-38500580-366D-41F9-87B7-F8629D2D735DQ43046177-9FF2805A-BDBB-4749-9F2E-4CDCAD1E23F4Q44952322-8ECB002C-E53C-4948-80F9-922C5A009B2FQ45559925-A56BB6F9-6E92-42A8-BE58-7A9A89628D88Q47207808-48672197-0C05-41F9-8368-A9EA88EC128DQ47586172-D14CA9DA-2E5F-49C5-A4F9-7ABBA1F91B9DQ47614692-B67867C3-CABF-42EF-A280-A80D48312125Q47696376-82830D79-63F5-42F7-A667-7DAE940CDF65Q53233695-A21DCA4F-EED7-478C-AE94-D2E268100231Q58220553-BBD35A66-E58E-4E05-AF96-2A06F050AE6EQ59182198-F5F15A81-2F32-4AC1-A8C6-EDA7B817BC06Q80605231-35563F55-DABF-440F-ACB7-55E488BDD8E0Q81843592-DD360AA7-0651-465A-808E-671704AFFCD4Q91739457-C2B42D3E-FC1B-4E6C-955F-06109D27CE48
P50
description
onderzoeker
@nl
researcher
@en
researcher
@en-gb
հետազոտող
@hy
name
Kakoli Das
@ast
Kakoli Das
@en
Kakoli Das
@en-gb
Kakoli Das
@es
Kakoli Das
@nl
Kakoli Das
@sl
type
label
Kakoli Das
@ast
Kakoli Das
@en
Kakoli Das
@en-gb
Kakoli Das
@es
Kakoli Das
@nl
Kakoli Das
@sl
prefLabel
Kakoli Das
@ast
Kakoli Das
@en
Kakoli Das
@en-gb
Kakoli Das
@es
Kakoli Das
@nl
Kakoli Das
@sl
P106
P1153
35317570200
P31
P496
0000-0002-0990-276X